Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes

NCT01720303 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: repaglinide
DRUG: isophane human insulin
DRUG: insulin

Sponsor

Novo Nordisk A/S